Prestige Biologics Co., Ltd. (KOSDAQ:334970)
South Korea · Delayed Price · Currency is KRW 2,445.00
-45.00 (-1.81%)
At close: Mar 19, 2026
Prestige Biologics Market Cap
Prestige Biologics has a market cap or net worth of 195.94 billion as of March 20, 2026. Its market cap has decreased by -43.00% in one year.
Market Cap
195.94B
Enterprise Value
279.30B
Revenue
19.24B
Ranking
n/a
PE Ratio
n/a
Stock Price
2,445.00
Market Cap Chart
Since March 11, 2021, Prestige Biologics's market cap has decreased from 613.27B to 195.94B, a decrease of -68.05%. That is a compound annual growth rate of -20.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 195.94B | -16.97% |
| Dec 30, 2025 | 235.98B | -40.12% |
| Dec 30, 2024 | 394.06B | 46.25% |
| Dec 28, 2023 | 269.45B | 46.01% |
| Dec 29, 2022 | 184.55B | -59.28% |
| Dec 30, 2021 | 453.18B | -26.10% |
| Mar 11, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genome & Company | 305.31B |
| Bio Solution | 301.19B |
| ABION | 259.94B |
| TiumBio | 252.40B |
| Kangstem Biotech | 250.65B |
| Ensol Biosciences | 207.51B |
| ISU Abxis | 202.79B |
| QuadMedicine | 178.55B |